Lobe Sciences Ltd. (CSE:LOBE)
Canada · Delayed Price · Currency is CAD 0.1250
-0.0100 (-7.41%)
May 21, 2026, 2:30 PM EST
Lobe Sciences Market Cap
Lobe Sciences has a market cap or net worth of CAD 38.35 million as of May 21, 2026. Its market cap has increased by 597.70% in one year.
Market Cap
38.35M
Enterprise Value
35.25M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.13
Market Cap Chart
Since June 7, 2019, Lobe Sciences's market cap has increased from 17.41M to 38.35M, an increase of 120.26%. That is a compound annual growth rate of 12.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 38.35M | 216.27% |
| Dec 30, 2025 | 12.13M | 164.72% |
| Dec 31, 2024 | 4.58M | 131.55% |
| Dec 29, 2023 | 1.98M | -35.51% |
| Dec 30, 2022 | 3.07M | -54.48% |
| Dec 31, 2021 | 6.74M | -73.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NurExone Biologic | 60.75M |
| Sernova Biotherapeutics | 58.44M |
| Quantum BioPharma | 54.10M |
| Medicenna Therapeutics | 45.05M |
| MedMira | 42.10M |
| Defence Therapeutics | 37.89M |
| Devonian Health Group | 31.01M |
| Microbix Biosystems | 31.00M |